Multidirectional Pharma-Toxicological Study on Harpagophytum procumbens DC. ex Meisn.: An IBD-Focused Investigation
Abstract
A water extract of Harpagophytum procumbens showed anti-inflammatory, antioxidant and antimicrobial activity in an experimental model of inflammatory bowel disease, supporting the anti-inflammatory use of devil's claw.
Referenced for these plants
How to cite
Recinella, L., Chiavaroli, A., Ronci, M., Menghini, L., Brunetti, L., Leone, S., Tirillini, B., Angelini, P., Covino, S., Venanzoni, R., Zengin, G., Di Simone, S., Ciferri, M.C., di Giacomo, V., Cataldi, A., Rapino, M., Valerio, V.D., Orlando, G. and Ferrante, C (2020) 'Multidirectional Pharma-Toxicological Study on Harpagophytum procumbens DC. ex Meisn.: An IBD-Focused Investigation', Antioxidants, 9(2), pp. 168. doi:10.3390/antiox9020168
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.